News
Monotherapy efficacy and safety profile provided backbone for clinical development strategy in 1L combination with nivolumab ...
Data show that simufilam reduced seizure activity in a preclinical mouse model Presentation also highlights favorable human ...
Disparities in multiple myeloma outcomes and the need for equitable care were the focus of 2 posters presented at the 2025 ...
The BCLA award ceremony in June recognised the skills of optometrists from around the world. OT heard from two award-winning ...
Genesis Research Group, a leading provider of tech-enabled real-world evidence (RWE), health economics and outcomes research ...
At the launch, the Group unveiled the high-end series of 肌顏態 ®-——GeneQueens TM (Human-Sequence Triple Protein Repair & Balance Ampoule). which functions on skin repair and anti-aging. By activating ...
2d
Vietnam Investment Review on MSNGeneQueens launches new aesthetic solutions at CSD2025HONG KONG SAR - EQS Newswire - 2 July 2025 - On June 27, 2025, Uni-Bio Science Group Limited (the "Group")grandly held a new medical aesthetics product launch event in Changsha, releasing the high-end ...
Research highlights improved lung cancer biomarker testing in North America, though delays, costs, and limited satisfaction persist despite clinician awareness.
The Jacobs School of Medicine and Biomedical Sciences had a strong showing at this year’s American Thoracic Society (ATS) 2025 annual conference in San Francisco in May, where a team of researchers ...
Designed to foster a blend of academic inquiry and clinical expertise, RHIMES 2025 provided a robust platform for budding and seasoned ENT professionals to engage in hands-on training and academic ...
4d
TipRanks on MSNCassava Sciences presents poster at TSC 2025 on SimufilamCassava Sciences (SAVA) announced that the Company presented a poster at the TSC International Research Conference held June 26-28, 2025 in ...
Long-term efficacy and safety data on PALSONIFYTM (paltusotine) in acromegaly to be presented, including evidence of both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results